BioSpace News Archive

Ainos, Inc., a diversified medtech company focused on the development of novel point-of-care testing, low-dose interferon therapeutics, and synthetic RNA-driven preventative medicine, announced its financial results for the fourth quarter and full year ended December 31, 2022.

The U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency.

Sarepta Therapeutics, Inc., the leader in precision genetic medicine for rare diseases, granted equity awards on March 31, 2023 that were previously approved by the Compensation Committee of its Board of Directors under Sarepta’s 2014 Employment Commencement Incentive Plan, as a material inducement to employment to 18 individuals hired by Sarepta in March 2023.

Athersys, Inc. announced financial results for the three and 12 months ended December 31, 2022, and provided a business update.

ABVC BioPharma, Inc., a biotechnology company specializing in botanically based solutions that seeks to deliver high efficacy and low toxicity to improve health outcomes, announced its financial and operating results for the fiscal year ended December 31, 2022.

Aridis Pharmaceuticals, Inc., a biopharmaceutical company, announced a corporate update on recent developments.

Belite Bio, Inc announced its financial results for the full-year ended December 31, 2022 and provided a general business update.

AnPac Bio-Medical Science Co., Ltd. announced that it has entered into a securities purchase agreement with certain institutional investors to purchase $3.0 million of its American Depositary Shares, pre-funded warrants to purchase ADSs and warrants to purchase ADSs in a registered direct offering.